Shire

Shire is a global biotechnology company focused on serving individuals with rare diseases and complex conditions. Established with a vision to transform the lives of patients, Shire develops innovative therapies that address unmet medical needs.

With a commitment to research and development, Shire invests significantly in discovering new treatments that can improve patient outcomes. The company’s portfolio includes a range of products that cater to various therapeutic areas, including hematology, immunology, neuroscience, and genetic disorders.

Shire operates in over 100 countries, ensuring that its life-changing therapies are accessible to patients worldwide. The company prides itself on its patient-centric approach, working closely with healthcare professionals and patient advocacy groups to understand the challenges faced by those living with rare diseases.

In addition to its focus on innovation, Shire is dedicated to sustainability and corporate responsibility. The company actively engages in initiatives that promote environmental stewardship and community support.

Core Values:

• Innovation: Continuously seeking new ways to improve patient care.
• Integrity: Upholding the highest ethical standards in all operations.
• Collaboration: Partnering with stakeholders to enhance treatment options.
• Compassion: Understanding and addressing the needs of patients and their families.

Shire’s mission is to empower patients through science, and its vision is to be the leading global biotechnology company in rare diseases. By harnessing the power of advanced technologies and scientific expertise, Shire aims to make a meaningful difference in the lives of those it serves.